OBJECTIVE: Vestibular schwannomas exhibit variable and unpredictable patterns of growth. We evaluated the extent to which tumor growth influences the management of these benign tumors, and we explored symptom markers present at diagnosis that may be predictive of tumor growth. STUDY DESIGN: Retrospective case review. SETTING: Tertiary care hospital center. PATIENTS: One hundred eighty patients with unilateral vestibular schwannomas diagnosed between 1997 and 2007 who were initially managed conservatively by serial observation. INTERVENTION(S): Serial observation versus eventual microsurgical or radiosurgical treatment. MAIN OUTCOME MEASURE(S): Tumor growth, defined as a 1 mm/year or greater increase in tumor size. RESULTS: We observed that tumor growth was the most important predictor of a change in treatment strategy from serial observation to microsurgical or radiosurgical treatment. We further noted in multivariate analyses that larger tumor size at diagnosis was associated with higher odds of tumor growth, such that each 1-mm increment in tumor size at presentation increased the odds of growth by 20%. We also found that the symptom marker of tinnitus at diagnosis significantly increased the odds of tumor growth nearly 3-fold. CONCLUSION: Tumor growth plays a significant role in guiding the management of vestibular schwannomas. Assessment of tumor size at diagnosis and for the presence of tinnitus may allow for risk stratification of patients with newly diagnosed vestibular schwannomas and for a more rational application of the conservative management approach.
OBJECTIVE:Vestibular schwannomas exhibit variable and unpredictable patterns of growth. We evaluated the extent to which tumor growth influences the management of these benign tumors, and we explored symptom markers present at diagnosis that may be predictive of tumor growth. STUDY DESIGN: Retrospective case review. SETTING: Tertiary care hospital center. PATIENTS: One hundred eighty patients with unilateral vestibular schwannomas diagnosed between 1997 and 2007 who were initially managed conservatively by serial observation. INTERVENTION(S): Serial observation versus eventual microsurgical or radiosurgical treatment. MAIN OUTCOME MEASURE(S): Tumor growth, defined as a 1 mm/year or greater increase in tumor size. RESULTS: We observed that tumor growth was the most important predictor of a change in treatment strategy from serial observation to microsurgical or radiosurgical treatment. We further noted in multivariate analyses that larger tumor size at diagnosis was associated with higher odds of tumor growth, such that each 1-mm increment in tumor size at presentation increased the odds of growth by 20%. We also found that the symptom marker of tinnitus at diagnosis significantly increased the odds of tumor growth nearly 3-fold. CONCLUSION:Tumor growth plays a significant role in guiding the management of vestibular schwannomas. Assessment of tumor size at diagnosis and for the presence of tinnitus may allow for risk stratification of patients with newly diagnosed vestibular schwannomas and for a more rational application of the conservative management approach.
Authors: Jacob B Hunter; David O Francis; Brendan P O'Connell; Edmond K Kabagambe; Marc L Bennett; George B Wanna; Alejandro Rivas; Reid C Thompson; David S Haynes Journal: Otol Neurotol Date: 2016-12 Impact factor: 2.311
Authors: Romain Kania; Benjamin Vérillaud; Domitille Camous; Charlotte Hautefort; Thomas Somers; Jérôme Waterval; Sébastien Froelich; Philippe Herman Journal: J Int Adv Otol Date: 2018-04 Impact factor: 1.017
Authors: Jason C Nellis; Jeff D Sharon; Seth E Pross; Lisa E Ishii; Masaru Ishii; Jacob K Dey; Howard W Francis Journal: Otol Neurotol Date: 2017-03 Impact factor: 2.311
Authors: Luis Lassaletta; Miguel Torres-Martín; Jesús San-Román-Montero; Javier S Castresana; Javier Gavilán; Juan Antonio Rey Journal: Eur Arch Otorhinolaryngol Date: 2012-11-21 Impact factor: 2.503
Authors: Gian Gaetano Ferri; Antonio Pirodda; Alberto Rinaldi Ceroni; Antonio Fioravanti; Fabio Calbucci; Giovanni Carlo Modugno Journal: Eur Arch Otorhinolaryngol Date: 2012-11-08 Impact factor: 2.503
Authors: Janet Leon; Eric J Lehrer; Jennifer Peterson; Laura Vallow; Henry Ruiz-Garcia; Austin Hadley; Steven Herchko; Larry Lundy; Kaisorn Chaichana; Prasanna Vibhute; Jason P Sheehan; Daniel M Trifiletti Journal: J Radiosurg SBRT Date: 2019
Authors: May N Tsao; Arjun Sahgal; Wei Xu; Antonio De Salles; Motohiro Hayashi; Marc Levivier; Lijun Ma; Roberto Martinez; Jean Régis; Sam Ryu; Ben J Slotman; Ian Paddick Journal: J Radiosurg SBRT Date: 2017
Authors: Oliver Profant; Zbyněk Bureš; Zuzana Balogová; Jan Betka; Zdeněk Fík; Martin Chovanec; Jan Voráček Journal: Sci Rep Date: 2021-09-15 Impact factor: 4.379